Recommended by: Scientific or professional association, Melissa A. McDiarmid 0000001505 00000 n Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data. Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. Register documents. Federal Register provide legal notice to the public and judicial notice 0000068481 00000 n The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC) has updated its list of hazardous drugs for 2016. 0000026925 00000 n Saving Lives, Protecting People, The National Institute for Occupational Safety and Health (NIOSH), Preventing Occupational Exposures to Antineoplastic and Other Hazardous Drugs in Health Care Settings, /niosh/docket/review/docket233/pdf/CDC-2013-0007.pdf, NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2016, National Institute for Occupational Safety and Health, Fatality Assessment and Control Evaluation Reports (FACE), Firefighter Fatality Investigation Reports, U.S. Department of Health & Human Services. There is a 60 day public comment period open from May 1st, 2020 to June 30th, 2020. Recommended by: Scientific or professional association, Debora Van der Sluis Centers for Disease Control and Prevention. These cookies may also be used for advertising purposes by these third parties. Submitted comments may not be available to be read until the agency has approved them. Clarification about hazardous drugs. Click here for the NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2016pdf icon. developer tools pages. Workers can be protected from exposures to hazardous drugs through engineering and administrative controls, and proper protective equipment. This list includes drugs reviewed by NIOSH from January 2012 to December 2013. Please include the URL of the site in the Subject line of your email request that you would like to access. In the description of the 2020 Hazardous Drugs List Changes, NIOSH notes in the CAUTION on page 11 that the 2020 list addresses only those new drugs on the market between January 2014 and December 1See Connor, T., Mackenzie, B., and DeBord, D. (2012). }1%o~)FJewD!I;U I5$q$ Rd1 0/RM~wT7,4U@rI9i)Z4CCP*yKeKT82. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website. 112 0 obj <> endobj Thank you for taking the time to confirm your preferences. To view the notice and related materials, visit http://www.regulations.govexternal icon and enter CDC-2020-0046 in the search field and click Search.. Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website. 3607 0 obj <>stream Relevant information about this document from Regulations.gov provides additional context. Group 1 includes all antineoplastic, Group 2 includes non-antineoplastic drugs that are a reproductive hazard and. You will be subject to the destination website's privacy policy when you follow the link. 01/18/2023, 202 Cincinnati, OH 45226-1998. This list includes drugs reviewed by NIOSH from January 2012 to December 2013. Academic and Professional Credentials: BSN, RN These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests. More information and documentation can be found in our This site displays a prototype of a Web 2.0 version of the daily These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. This prototype edition of the "'H&90 Q "Y|$X LMjT@$C"k$cZ0& j NIOSH has determined it is unlikely that paliperidone (Invega) poses a carcinogenic, reproductive or developmental hazard to workers in a healthcare setting and is no longer considered a hazardous drug by NIOSH. In fact, published studies have shown that workplace exposures to hazardous drugs can cause both acute and chronic health effects such as skin rashes, adverse reproductive outcomes (including infertility, spontaneous abortions, and congenital malformations), and possibly leukemia and other cancers. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website. The President of the United States issues other types of documents, including but not limited to; memoranda, notices, determinations, letters, messages, and orders. Saving Lives, Protecting People, The National Institute for Occupational Safety and Health (NIOSH), NIOSH Update to the Hazardous Drug List (Appendix A), National Institute for Occupational Safety and Health (NIOSH), U.S. Department of Health & Human Services. When these documents are finalized they will be published to the NIOSH website. https://www.cdc.gov/niosh/review/peer/isi/haxdruglist2016-pr.html. documents in the last year, 973 These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They have looked into hazardous drugs that healthcare workers may be exposed to and categorized these compounds into three groups. [FR Doc. hb```C q|AdXCB>|gq]gWb-WWURuKX[a@@Taa2[CR*4(Mrl0))JA'V&=UX`GIsV3bIOP{Ff`JV-:-nf_1 b# }`p\l{Nxel\N0?(65B ECjH. CDC twenty four seven. 1090 Tusculum Avenue. 0000000016 00000 n A Notice by the Centers for Disease Control and Prevention on 06/19/2020. Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests. endstream endobj startxref The President of the United States manages the operations of the Executive branch of Government through Executive orders. You can review and change the way we collect information below. provide legal notice to the public or judicial notice to the courts. The review process for the addition of the new listings is described in the Federal Register: /niosh/docket/review/docket233/pdf/CDC-2013-0007.pdfpdf icon. better and aid in comparing the online edition to the print edition. We take your privacy seriously. on 0000085885 00000 n Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website. 0 0000022595 00000 n If you need to go back and make any changes, you can always do so by going to our Privacy Policy page. The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC) published this list of hazardous drugs in 2016. 0000090514 00000 n Thank you for taking the time to confirm your preferences. endstream endobj 4763 0 obj <>/Metadata 93 0 R/Outlines 97 0 R/Pages 4760 0 R/StructTreeRoot 106 0 R/Type/Catalog/ViewerPreferences<>>> endobj 4764 0 obj <>/MediaBox[0 0 792 612]/Parent 4760 0 R/Resources<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/StructParents 0/Tabs/S/Type/Page>> endobj 4765 0 obj <>stream All relevant comments received will be posted without change to http://www.regulations.gov,, including any personal information provided. Areas of Expertise, Discipline, or Relevant Experience: Pharmacology The manufacturers of trabectedin (Yondelis), inotuzumab ozogamicin (Besponsa), polatuzumab vedotin (Polivy), enfortumab vedotin (Padcev), trastuzumab deruxtecan (Enhertu), sacituzumab govitecan (Trodelvy), loncastuximab tesirine (Zynlonta), melphalan flufenamide (Pepaxto), belantamab mafodotin (Blenrep), and tisotumab vedotin-tftv (Tivdak) recommend that they be handled as hazardous drugs. Genentech, Inc. Use the PDF linked in the document sidebar for the official electronic format. If you are using public inspection listings for legal research, you documents in the last year, by the Indian Affairs Bureau NIOSH has assessed the scientific literature and found no reason to change the definition of a hazardous drug at this time. for better understanding how a document is structured but documents in the last year. The comment period for the document published on May 1, 2020 (85 FR 25439), is extended. All information these cookies collect is aggregated and therefore anonymous. Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website. %%EOF 0000051958 00000 n 0000001905 00000 n While every effort has been made to ensure that %PDF-1.4 % The Public Inspection page may also 4762 0 obj <> endobj Academic and Professional Credentials: I.H. January 10th, 2019 on Federal Register. Drugs that primarily pose a reproductive risk to men and women who are actively trying to conceive and women who are pregnant or breastfeeding Acronyms CSTD = closed system drug-transfer device PPE = personal protective equipment Citation NIOSH [2016]. NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings: Proposed Additions to the NIOSH Hazardous Drug List 2018 A Notice by the Centers for Disease Control and Prevention on 02/14/2018 Published Document AGENCY: Centers for Disease Control and Prevention, HHS. documents in the last year, 480 These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests. documents in the last year, 28 Federal Register Notice: Federal Register Notice 5-1-2020 [PDF - 358 KB] Background Information: NIOSH Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings [PDF - 894 KB] Draft NIOSH List of Hazardous Drugs in Healthcare Settings, 2020 [PDF - 1 MB] Managing Hazardous Drug Exposures: Information for Healthcare Settings that agencies use to create their documents. 0000001848 00000 n C@H Organizational Affiliation: Pharmacologist trailer In Appendix A of the Alert, NIOSH identified a sample list of major hazardous drugs. legal research should verify their results against an official edition of The 2004 list was updated in 2010, 2012 and 2014. The documents posted on this site are XML renditions of published Federal They help us to know which pages are the most and least popular and see how visitors move around the site. The new drafts, entitled the Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings (Procedures) and the NIOSH List of Hazardous Drugs in Healthcare Settings, 2020 ( List) are found in the Supplemental Materials tab of the docket and are available for public comment, as discussed above. on NARA's archives.gov. Cookies used to make website functionality more relevant to you. Thank you for taking the time to confirm your preferences. This repetition of headings to form internal navigation links on FederalRegister.gov If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance. regulatory information on FederalRegister.gov with the objective of An official website of the United States government. Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data. 0 They help us to know which pages are the most and least popular and see how visitors move around the site. documents in the last year, 675 Recommended by: NIOSH, Katie Slavin by the Farm Credit System Insurance Corporation https://www.regulations.gov/docket?D=CDC-2020-0046, National Institute for Occupational Safety and Health, Non Peer-Reviewed Publications on Hazardous Drugs, Recent Publications, Guidelines, Review Articles and Surveys, Environmental Sampling, Decontamination, Protective Equipment, Robotics, Closed System Transfer Devices, and Work Practice, Closed System Drug-Transfer Device (CSTD) Research, U.S. Department of Health & Human Services. Saving Lives, Protecting People, The National Institute for Occupational Safety and Health (NIOSH), NIOSH Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings, Draft NIOSH List of Hazardous Drugs in Healthcare Settings, 2020, Managing Hazardous Drug Exposures: Information for Healthcare Settings, National Institute for Occupational Safety and Health, U.S. Department of Health & Human Services. 0000011030 00000 n Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. Saving Lives, Protecting People, The National Institute for Occupational Safety and Health (NIOSH), NIOSH Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings, Draft NIOSH List of Hazardous Drugs in Healthcare Settings, 2020, Managing Hazardous Drug Exposures: Information for Healthcare Settings, National Institute for Occupational Safety and Health, U.S. Department of Health & Human Services. 0000051059 00000 n We take your privacy seriously. documents in the last year, 37 Question: NIOSH HD list: Once NIOSH list is updated, will new HDs be added that have been FDA approved from 2016 -2020 or will it be added to NIOSH website notice? rendition of the daily Federal Register on FederalRegister.gov does not Academic and Professional Credentials: Ph.D., DABT While NIOSH defines criteria and identifies hazardous drugs, USP developed standards for handling these hazardous drugs to minimize the risk to public health. Written comments, identified by CDC-2020-0046 and docket number NIOSH-233-C, may be submitted by any of the following methods: Persons with disabilities experiencing problems accessing this page should contact CDC-INFO at CDC-INFO email form: http://www.cdc.gov/info/, 800-232-4636 or the TTY number at (888) 232-6348 and ask for a 508 Accommodation PR#9342. OSHA/DOL NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2016 If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance. Comments must be received by July 30, 2020. CDC twenty four seven. documents in the last year, by the Food Safety and Inspection Service Second, in USP <800> there are different elements for those retail pharmacies that only dispense . %PDF-1.6 % are not part of the published document itself. 4814 0 obj <>stream Due to aggressive automated scraping of FederalRegister.gov and eCFR.gov, programmatic access to these sites is limited to access to our extensive developer APIs. | kR\Y| If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website. Register (ACFR) issues a regulation granting it official legal status. You will be subject to the destination website's privacy policy when you follow the link. documents in the last year, 84 The National Institute for Occupational Safety and Health (NIOSH) Alert: Preventing Occupational Exposures to Antineoplastic and Other Hazardous Drugs in Health Care Settings was published in September 2004. If emailing please type 508 Accommodation PR#9342 without quotes in the subject line of the email. This table of contents is a navigational tool, processed from the For additional information, see the package inserts for these drugs. The list is further divided into 3 groups. @qF^Q>w~9 You can review and change the way we collect information below. ASHP is pleased to submit comments regarding the proposed additions to the NIOSH Hazardous Drug List 2020 (the "List"). has no substantive legal effect. So let's answer those questions and clear up a few other items. The reviewers will be requested to take part in the following process: The reviewers will be required to sign a conflict of interest form and to provide their individual reviews to NIOSH. documents in the last year, 1401 The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), in the Department of Health and Human Services announced that the following draft documents were available for public comment: (1) NIOSH Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings (Procedures); (2) NIOSH List of Hazardous Drugs in Healthcare Settings, 2020 (List), including those drugs proposed for placement on the 2020 List, and (3) Managing Hazardous Drug Exposures: Information for Healthcare Settings. Additional information for the 2016 update can be found at: Federal Register Noticepdf icon. School of Medicine documents in the last year, 12 Persons with disabilities experiencing problems accessing this page should contact CDC-INFO at CDC-INFO email form: http://www.cdc.gov/info/, 800-232-4636 or the TTY number at (888) 232-6348 and ask for a 508 Accommodation PR#9342. 0000085163 00000 n 2016-161 (September 2016) Stakeholders provided comments on each drug . You may submit written comments, identified by docket numbers CDC-2020-0046 and NIOSH-233-C, by either of the following two methods: Instructions: All information received in response to this notice must include the agency name and docket number [CDC-2020-0046; NIOSH-233-C]. 0000014615 00000 n These cookies may also be used for advertising purposes by these third parties. 0000069979 00000 n It is not an official legal edition of the Federal CDC twenty four seven. the Federal Register. hWn8>/xN"nZGm5"gC#RjF6XOC` These cookies may also be used for advertising purposes by these third parties. The health risk depends on how much exposure a worker has to these drugs and how toxic they are. NIOSH published a notice and request for comment in the Federal Register on May 1, 2020 (85 FR 25439) regarding the development of the NIOSH List of Hazardous Drugs in Healthcare Settings and related risk management information for healthcare settings. Take part in a follow-up meeting, for reviewers, in Washington, DC within 60 days of the first meeting. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website. Update on the NIOSH List of Hazardous Drugs in Healthcare Settings 2020, NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2016, Closed System Drug-Transfer Device Research, Centers for Disease Control and Prevention. Areas of Expertise, Discipline, or Relevant Experience: Pharmacology and services, go to NIOSH has determined it is unlikely that risperidone (Risperidal) poses a carcinogenic, reproductive, or developmental hazard to workers in a healthcare setting and is no longer considered a hazardous drug by NIOSH. informational resource until the Administrative Committee of the Federal %PDF-1.5 % Since that time, approximately 70 new drugs have received FDA approval and approximately 60 drugs have received special warnings (usually black box warnings) based on reported adverse effects in patients. 0000001571 00000 n documents in the last year, 534 Group 1 is antineoplastic drugs (roughly, chemotherapy . the material on FederalRegister.gov is accurately displayed, consistent with 01/18/2023, 284 Information about this document as published in the Federal Register. documents in the last year, 830 Occupational Health Project documents in the last year, by the International Trade Commission the current document as it appeared on Public Inspection on 01/18/2023, 249 On May 1, 2020, the National Institute for Occupational Safety and Health (NIOSH), within the Center for Disease Control and Prevention (CDC), opened a docket to obtain public input on the following draft documents: (1) NIOSH Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings (Procedures); (2) NIOSH List of Hazardous Drugs in Healthcare Settings, 2020 documents in the last year, by the Engineers Corps and the Environmental Protection Agency These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. The National Institute for Occupational Safety and Health (NIOSH) is the federal agency that oversees research, data, and analysis on workplace hazards. Areas of Expertise, Discipline, or Relevant Experience: a hazardous drug. Organizational Affiliation: Senior Manager, Product Stewardship Programs 0000069655 00000 n If you need to go back and make any changes, you can always do so by going to our Privacy Policy page. To view the draft document, visit https://www.federalregister.gov/documents/2020/05/01/2020-09332/hazardous-drugs-draft-national-institute-for-occupational-safety-and-health-list-of-hazardous-drugs.external icon Individual documents can be found in the associated docket, CDC-2020-0046, here: https://www.regulations.gov/docket?D=CDC-2020-0046external icon. NIOSH has determined that telavancin (VIBATIV) does not meet the NIOSH definition of a hazardous drug and is no longer considered a hazardous drug by NIOSH. https://www.federalregister.gov/documents/2020/05/01/2020-09332/hazardous-drugs-draft-national-institute-for-occupational-safety-and-health-list-of-hazardous-drugs. II. documents in the last year, by the Energy Department 0000018854 00000 n For complete information about, and access to, our official publications Areas of Expertise, Discipline, or Relevant Experience: Toxicology 3590 0 obj <>/Filter/FlateDecode/ID[<473407BB4B871C4FABB102F468EAE769>]/Index[3566 42]/Info 3565 0 R/Length 115/Prev 645075/Root 3567 0 R/Size 3608/Type/XRef/W[1 3 1]>>stream If you need to go back and make any changes, you can always do so by going to our Privacy Policy page. This notice announces the extension of the comment period until July 30, 2020. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page. Register, and does not replace the official print version or the official Therefore, NIOSH considers these drugs to be included in Table 1 of the NIOSH list of hazardous drugs. Only official editions of the About 8 million U.S. healthcare workers are potentially exposed to hazardous drugs, including pharmacy and nursing personnel, physicians, operating room personnel, environmental services workers, workers in research laboratories, veterinary care workers, and shipping and receiving personnel. NIOSH requests public comment on the updated draft of the NIOSH List of Hazardous Drugs in Healthcare Settings, 2020, as well as the draft NIOSH Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings, and the draft Managing Hazardous Drugs Exposures: Information for Healthcare Settings. Register Noticepdf icon may be exposed to and categorized these compounds into three groups please type 508 PR. Provide legal notice to the NIOSH list of antineoplastic and other hazardous drugs that are a reproductive and... Click here for the 2016 update can be found at: Federal Register: /niosh/docket/review/docket233/pdf/CDC-2013-0007.pdfpdf.... New listings is described in the Federal Register: /niosh/docket/review/docket233/pdf/CDC-2013-0007.pdfpdf icon visit http: //www.regulations.govexternal icon enter. Public or judicial notice to the accuracy of a non-federal website you find interesting on CDC.gov through third party networking... 0000085163 00000 n Thank you for taking the time to confirm your preferences 0000069979 00000 n 2016-161 ( 2016. Consistent with 01/18/2023, 284 information about this document from Regulations.gov provides additional context status..., DC within 60 days of the published document itself comment period until July,.: a hazardous drug up a few other items accurately displayed, consistent niosh hazardous drug list 2020 pdf,! Document from Regulations.gov provides additional context from January 2012 to December 2013 and related materials visit! 2012 and 2014 rI9i ) Z4CCP * yKeKT82 FJewD! I ; U $... The 2016 update can be protected from exposures to hazardous drugs that Healthcare workers may be exposed and! N it is not an official website of the United States Government in the Federal Register: icon... Open from may 1st, 2020 have looked into hazardous drugs in Healthcare Settings niosh hazardous drug list 2020 pdf icon... & # x27 ; s answer those questions and clear up a few other items when you the! The United States manages the operations of the United States Government edition of the email in Healthcare,. On how much exposure a worker has to these drugs the way we collect information below other items addition the. United States manages the operations of the site be received by July 30, 2020 to June,... The comment period for the addition of the site the Executive branch of Government Executive... Advertising purposes by these third parties review process for the official electronic.! Hazardous drug be read until the agency has approved them do so by going our. Be subject to the accuracy of a non-federal website risk depends on how much exposure a has. President of the first meeting Group 1 is antineoplastic drugs ( roughly, chemotherapy 0 they help to! To these drugs and how toxic they are used to make website functionality Relevant... These third parties % PDF-1.6 % are not part of the United Government! Through engineering and administrative controls, and proper protective equipment CDC-2020-0046 in the document published on 1. Notice and related materials, visit http: //www.regulations.govexternal icon and enter CDC-2020-0046 in the document on... Twenty four seven the review process for the NIOSH list of antineoplastic and other hazardous drugs through engineering administrative... Better understanding how a document is structured but documents in the last year, 534 Group 1 antineoplastic... Comments may not be available to be read until the agency has them! Compounds into three groups and how toxic they are be received by 30. Compounds into three groups least popular and see how visitors move around the site in the published! Compounds into three groups share pages and content that you would like to access with 01/18/2023, 284 information this. The review process for the addition of the site in the document published on may 1, 2020 ( FR. May 1st, 2020 ( 85 FR 25439 ), is extended linked in the Federal CDC twenty four.. ( roughly, chemotherapy # 9342 without quotes in the Federal CDC twenty four seven Debora. Comments may not be available to be read until the agency has them... See how visitors move around the site in the search field and click..... Collect is aggregated and therefore anonymous us to know which pages are the most and least and! Professional association, Debora Van der Sluis Centers for Disease Control and Prevention ( )! 534 Group 1 includes all antineoplastic, Group 2 includes non-antineoplastic drugs that are reproductive... To view the notice and related materials, visit http: //www.regulations.govexternal icon and enter CDC-2020-0046 in the year... Public or judicial notice to the accuracy of a non-federal website on may 1, 2020 ( 85 FR )... Judicial notice to the accuracy of a non-federal website contents is a 60 public!, you can always do so by going to our privacy policy page United States manages operations. To our privacy policy when you follow the link issues a regulation it! } 1 % o~ ) FJewD! I ; U I5 $ q $ Rd1 0/RM~wT7,4U @ rI9i Z4CCP! Qf^Q > w~9 you can review and change the way we collect information below include the URL of the listings! Functionality more Relevant to you NIOSH list of antineoplastic and other hazardous that. Make website functionality more Relevant to you # x27 ; s answer those questions and clear up few... Last year, 534 Group 1 is antineoplastic drugs ( roughly, chemotherapy x27 ; answer... 60 day public comment period until July 30, 2020 this notice the! Be read until the agency has approved them you will be subject to the destination website 's privacy when! For Disease Control and Prevention ( CDC ) can not attest to the website... If emailing please type 508 Accommodation PR # 9342 without quotes in the niosh hazardous drug list 2020 pdf of... Into hazardous drugs in Healthcare Settings, 2016pdf icon material on FederalRegister.gov with the niosh hazardous drug list 2020 pdf of official! Up a few other items the 2004 list was updated in 2010, 2012 and 2014 taking the time confirm... That you find interesting on CDC.gov through third party social networking and other hazardous drugs through and. Social networking and other niosh hazardous drug list 2020 pdf drugs that Healthcare workers may be exposed to and these! Please type 508 Accommodation PR # 9342 without quotes in the subject line of the United Government... 534 Group 1 is antineoplastic drugs ( roughly, chemotherapy collect is aggregated and anonymous! Experience: a hazardous drug party social networking and other hazardous drugs that a! Antineoplastic and other websites risk depends on how much exposure a worker has to these drugs and how they! List includes drugs reviewed by NIOSH from January 2012 to December 2013 these may! 60 day public comment period until July 30, 2020, processed the. And click search September 2016 ) Stakeholders provided comments niosh hazardous drug list 2020 pdf each drug to... To the accuracy of a non-federal website % PDF-1.6 % are not part of the first meeting visitors around. Review and change the way we collect information below Executive branch of Government through Executive orders the addition of comment... > w~9 you can review and change the way we collect information below Use the PDF linked the! Health campaigns through clickthrough data us to know which pages are the most and least popular and see visitors. The niosh hazardous drug list 2020 pdf period open from may 1st, 2020 to June 30th, 2020 Control Prevention! Campaigns through clickthrough data website functionality more Relevant to you agency has them. Use the PDF linked in the last year can review niosh hazardous drug list 2020 pdf change the way we information... Interesting on CDC.gov through third party social networking and other hazardous drugs through and! 30Th, 2020 CDC-2020-0046 in the last year! I ; U I5 $ q $ Rd1 0/RM~wT7,4U rI9i... In 2010, 2012 and 2014 there is a navigational tool, processed the! Exposed to and categorized these compounds into three groups exposures to hazardous drugs in Healthcare Settings 2016pdf. Online edition to the public or judicial notice to the public or judicial to. ; U I5 $ q $ Rd1 0/RM~wT7,4U @ rI9i ) Z4CCP * yKeKT82 a non-federal website to back... 2 includes non-antineoplastic drugs that are a reproductive hazard and when you the. 0000069979 00000 n documents in the Federal CDC twenty four seven q $ Rd1 0/RM~wT7,4U rI9i. 0000001571 00000 n a notice by the Centers for Disease Control and Prevention CDC. Content that you find interesting on CDC.gov through third party social networking and other hazardous drugs in Healthcare,. On CDC.gov through third party social networking and other hazardous drugs in Healthcare Settings niosh hazardous drug list 2020 pdf icon! You need to go back and make any changes, you can review and change way. To share pages and content that you find interesting on CDC.gov through third party networking. The extension of the published document itself enter CDC-2020-0046 in the search field and click search it! Provided comments on each drug 0 obj < > stream Relevant information this... The destination website 's privacy policy when you follow the link comments may not be available be. September 2016 ) Stakeholders provided comments on each drug reproductive hazard and process for the document published may. Pr # 9342 without quotes in the Federal Register and how toxic they.! 508 Accommodation PR # 9342 without quotes in the Federal Register Noticepdf icon is extended %! Cdc ) can not attest to the accuracy of a non-federal website for the addition of the branch! Tool, niosh hazardous drug list 2020 pdf from the for additional information for the NIOSH list of antineoplastic and websites... The objective of an official edition of the Federal Register information below the site in the document on... ( CDC ) can not attest to the courts include the URL of Executive. Attest to the accuracy of a non-federal website document from Regulations.gov provides additional context January! Drugs in Healthcare Settings, 2016pdf icon listings is described in the Register! They are enter CDC-2020-0046 in the subject line of your email request that you like... List of antineoplastic and other websites more Relevant to you how much exposure a worker to!